Observational Study on Second Line Treatment of Colorectal Liver Metastases (KRas wt) by Hepatic Intra-arterial Chemoembolization With Dc Beads 70-150 μm Microspheres Preloaded With Irinotecan 200 Mgr Plus Systemic Cetuximab

Trial Profile

Observational Study on Second Line Treatment of Colorectal Liver Metastases (KRas wt) by Hepatic Intra-arterial Chemoembolization With Dc Beads 70-150 μm Microspheres Preloaded With Irinotecan 200 Mgr Plus Systemic Cetuximab

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 May 2015

At a glance

  • Drugs Cetuximab (Primary) ; Irinotecan
  • Indications Colon cancer; Liver metastases
  • Focus Therapeutic Use
  • Acronyms TACETUX
  • Most Recent Events

    • 12 May 2015 Status changed from recruiting to completed, according to to ClinicalTrials.gov record.
    • 16 Apr 2015 Planned End Date changed from 1 Jun 2014 to 1 Jun 2016 as reported by ClinicalTrials.gov
    • 16 Apr 2015 Planned primary completion date changed to 1 May 2016 as reported by ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top